Jean-Frederic Viret
CIK 1427569 · Chief Financial Officer · last filed 2026-02-09
Jean-Frederic Viret is a Chief Financial Officer who has filed 43 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for SGP, was dated Feb 9, 2026. Across all open-market trades the lifetime net is −$2.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $96.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$96.2K
4
43
-$2.85M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SGP | Chief Financial Officer | — | $18.44 | — | $0 | 1 | 2026-02-09 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Chief Financial Officer | 0 | $1.54 | $0 | $0 | 2 | 2024-04-08 |
| CHRS | Chief Financial Officer | 68,697 | $1.40 | $96.2K | -$2.85M | 36 | 2021-02-03 |
| ANESIVA, INC. (ANSV) Delisted | VP and Chief Financial Officer | 6,541 | — | — | $0 | 2 | 2008-12-05 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-09 | SGP | Grant (A) | — | $0 | EDGAR |
| 2024-04-08 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Mixed | −3,038 | $0 | EDGAR |
| 2023-12-04 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-03 | CHRS | Mixed | — | -$85.1K | EDGAR |
| 2021-01-27 | CHRS | Mixed | −6,144 | -$518.7K | EDGAR |
| 2021-01-13 | CHRS | Grant (A) | +31,250 | $0 | EDGAR |
| 2021-01-12 | CHRS | Tax (F) | −4,080 | -$74.2K | EDGAR |
| 2020-11-19 | CHRS | Mixed | −495 | -$14.6K | EDGAR |
| 2020-10-16 | CHRS | Sell (S) | −6,144 | -$116.7K | EDGAR |
| 2020-05-22 | CHRS | Sell (S) | −1,278 | -$22.6K | EDGAR |